
With the federal government's negotiation of prescription prices with drug companies about to get underway, amicus curiae briefs in suits seeking to overturn the program give a glimpse of the coming legal battle. A plan to negotiate prices of prescription drugs covered under Medicare is facing multiple lawsuits from drugmakers, including at least four cases in New Jersey.
Biotech & Pharmaceuticals
January 19, 2024, 2:54 PM